ロード中...
Engineering chimeric antigen receptor-T cells for cancer treatment
Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment. Recently, chimeric antigen receptor (CAR) T-cell therapy has been successfully applied in the treatment of B-cell malignancies, underscorin...
保存先:
| 出版年: | Mol Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815249/ https://ncbi.nlm.nih.gov/pubmed/29448937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0814-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|